Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Next step: End-of-Phase 2 FDA meeting planned in Q2 2026, with Phase 3 trials expected to begin in H2 2026
TB-500: Touted for systemic, full-body recovery, reduced inflammation, and improved flexibility
Contact your insurance provider directly for more coverage details
Patients often report brighter, plumper skin with improved hydration, a smoother texture, and reduced fine lines, which become visible after several sessions
however, no G6PD deficiency has been reported in this unique situation because all affected patients are heterozygotes and presumably in the blood there is overwhelming selection in favor of the cells in which the active X chromosome has the normal Gd allele
Several animal models showed that treatment with GLPs may lead to improvement of colitis
US$ 24.17
US$ 23.65
US$ 23.97
US$ 20.36
